Posted by admin on May 25th, 2022

Bath & Body Works (NYSE:BBWI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday, Zacks.com reports.

According to Zacks, “Bath & Body Works is a specialty retailers and home to America’s Favorite Fragrances(R) offering exclusive fragrances for the body and home, fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Bath & Body Works, formerly known as L BRANDS INC, is based in COLUMBUS, Ohio. “

Several other brokerages have also commented on BBWI. Barclays decreased their target price on shares of Bath & Body Works from $53.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Friday, May 20th. Cowen decreased their target price on shares of Bath & Body Works from $82.00 to $60.00 and set an “outperform” rating on the stock in a research report on Friday, May 20th. JPMorgan Chase & Co. decreased their target price on shares of Bath & Body Works from $81.00 to $67.00 in a research report on Monday, May 16th. Telsey Advisory Group cut their price target on Bath & Body Works from $70.00 to $60.00 and set an “outperform” rating for the company in a research note on Thursday, May 19th. Finally, B. Riley cut their price target on Bath & Body Works from $76.00 to $67.00 and set a “buy” rating for the company in a research note on Friday, May 20th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Buy” and a consensus target price of $66.20.

NYSE:BBWI traded up $3.15 during midday trading on Wednesday, reaching $39.30. The stock had a trading volume of 5,418,872 shares, compared to its average volume of 4,964,856. The firm has a fifty day simple moving average of $49.57 and a two-hundred day simple moving average of $58.13. Bath & Body Works has a 12-month low of $35.46 and a 12-month high of $82.00. The stock has a market cap of $9.37 billion, a P/E ratio of 8.56, a P/E/G ratio of 1.11 and a beta of 1.56.

Bath & Body Works (NYSE:BBWI – Get Rating) last posted its quarterly earnings data on Wednesday, May 18th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.11. Bath & Body Works had a net margin of 15.41% and a negative return on equity of 83.19%. As a group, sell-side analysts expect that Bath & Body Works will post 3.9 EPS for the current year.

In related news, CFO Wendy C. Arlin sold 6,000 shares of the business’s stock in a transaction dated Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total value of $330,000.00. Following the completion of the transaction, the chief financial officer now owns 98,888 shares of the company’s stock, valued at approximately $5,438,840. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.37% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. AlphaCrest Capital Management LLC purchased a new stake in Bath & Body Works in the 3rd quarter valued at about $363,000. American Century Companies Inc. purchased a new stake in Bath & Body Works in the 3rd quarter valued at about $10,493,000. Public Sector Pension Investment Board purchased a new stake in Bath & Body Works in the 3rd quarter valued at about $2,818,000. Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Bath & Body Works in the 3rd quarter valued at about $11,375,000. Finally, Hennion & Walsh Asset Management Inc. purchased a new stake in Bath & Body Works in the 3rd quarter valued at about $371,000. Institutional investors own 97.11% of the company’s stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Get a free copy of the Zacks research report on Bath & Body Works (BBWI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.

Oracle Co. (NYSE:ORCL) Expected to Post Earnings of $1.36 Per Share

Jardine Matheson Holdings Limited (OTCMKTS:JMHLY) Short Interest Down 84.2% in May